Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype

Acta Biomaterialia

Volumn 6, Issue 7, 2010, Pages 2621-2630

  Kou, Peng Meng ^a   Babensee, Julia E ^a  

^a Emory University   (United States)

Author keywords

Biomaterials; Dendritic cells; High throughput screening; Tissue engineering; Vaccine delivery

Indexed keywords

BIOMATERIALS; CELL ENGINEERING; CYTOLOGY; IMMUNE SYSTEM; THROUGHPUT; TISSUE; TISSUE REGENERATION; VACCINES;

CELL PHENOTYPE; COMBINATION PRODUCTS; DENDRITIC CELL; DENDRITICS; FILTER PLATES; HIGH THROUGHPUT SCREENING; HIGH-THROUGHPUT; HOST IMMUNE RESPONSE; TISSUES ENGINEERINGS; VACCINE DELIVERY;

CELLS;

BIOMATERIAL; VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; TISSUE ENGINEERING; VALIDATION STUDY;

BIOCOMPATIBLE MATERIALS; DENDRITIC CELLS; HUMANS; PHENOTYPE;

EID: 77955915569     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.023     Document Type: Article

References (54)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
2. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002;2:151-61.
3. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19-30.
4. Ouaaz F, Arron J, Zheng Y, Choi YW, Beg AA. Dendritic cell development and survival require distinct NF-kappa B subunits. Immunity 2002;16:257-70.
5. Pulendran B, Palucka K, Banchereau J. Sensing pathogens and tuning immune responses. Science 2001;293:253-6.
6. Janeway CA, Medzhitov R. Innate immunity: lipoproteins take their toll on the host. Curr Biol 1999;9: R879-82.
7. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45.
8. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-9.
9. Banchereau J et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
10. Trinchieri G, Sher A. Cooperation of toll-like receptor signals in innate immune defense. Nat Rev Immunol 2007;7:179-90.
11. West MA et al. Enhanced dendritic cell antigen capture via toll-like receptorinduced actin remodeling. Science 2004;305:1153-7.
12. Kalinski P, Hilkens CMU, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999;20:561-7.
13. van Kooyk Y, Geijtenbeek TBH. DC-sign: escape mechanism for pathogens. Nat Rev Immunol 2003;3:697-709.
14. Kwissa M, Kasturi SP, Pulendran B. The science of adjuvants. Expert Rev Vaccines 2007;6:673-84.
15. Gupta RK, Siber GR. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 1995;13:1263-76.
16. Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999;17:1075-81.
17. Alving CR. Design and selection of vaccine adjuvants: animal models and human trials. Vaccine 2002;20: S56-64.
18. Bennewitz NL, Babensee JE. The effect of the physical form of poly (lactic-coglycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 2005;26:2991-9.
19. Matzelle MM, Babensee JE. Humoral immune responses to model antigen codelivered with biomaterials used in tissue engineering. Biomaterials 2004;25:295-304.
20. Babensee JE, Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 2005;74 A: 503-10.
21. Yoshida M, Babensee JE. Differential effects of agarose and poly (lactic-coglycolic acid) on dendritic cell maturation. J Biomed Mater Res A 2006;79 A: 393-408.
22. Yoshida M, Babensee JE. Poly (lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004;71 A: 45-54.
23. Selkirk JV, Nottebaum LM, Ford IC, Santos M, Malany S, Foster AC, et al. A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation. J Biomol Screen 2006;11:351-8.
24. Greenwalt DE, Szabo J, Manchel I. High throughput cell-based assay of hematopoietic progenitor differentiation. J Biomol Screen 2001;6:383-92.
25. Romani N et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
26. Jotwani R, Pulendran B, Agrawal S, Cutler CW. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur J Immunol 2003;33:2980-6.
27. Lundholt BK, Scudder KM, Pagliaro L. A simple technique for reducing edge effect in cell-based assays. J Biomol Screen 2003;8:566-70.
28. Shankar SP, Babensee JE. Comparative characterization of cultures of primary human macrophages or dendritic cells for biomaterials studies. J Biomed Mater Res A 2010;92:791-800.
29. Kaser A et al. B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol 2000;165:2474-80.
30. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 2005;175:15-20.
31. Bayry J et al. Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci USA 2004;101:14210-5.
32. Folzenlogen D, Hofer MF, Leung DY, Freed JH, Newell MK. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997;83:199-204.
33. Cao XC, Sugita M, van der Wel N, Lai J, Rogers RA, Peters PJ, et al. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J Immunol 2002;169:4770-7.
34. Anderson DG, Levenberg S, Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol 2004;22:863-6.
35. Anderson DG, Putnam D, Lavik EB, Mahmood TA, Langer R. Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials 2005;26:4892-7.
36. Jefford M et al. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 2003;102:1753-63.
37. Sozzani S et al. Human monocyte-derived and CD34 (+) cell-derived dendritic cells express functional receptors for platelet activating factor. FEBS Lett 1997;418:98-100.
38. Jansen JH, Wientjens G, Fibbe WE, Willemze R, Kluinnelemans HC. Inhibition of human macrophage colony formation by interleukin-4. J Exp Med 1989;170:577-82.
39. Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ. Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci USA 1999;96:15056-61.
40. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
41. Jeannin P, Delneste Y, Lecoanet Henchoz S, Gauchat JF, Ellis J, Bonnefoy JY. CD86 (B7-2) on human B cells - a functional role in proliferation and selective differentiation into IgE-and IgG4-producing cells. J Biol Chem 1997;272:15613-9.
42. Beckman EM et al. CD1c restricts responses of mycobacteria-specific T cells - evidence for antigen presentation by a second member of the human CD1 family. J Immunol 1996;157:2795-803.
43. Briken V, Jackman RM, Watts GFM, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 2000;192:281-7.
44. Im JS et al. Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. J Biol Chem 2004;279:299-310.
45. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004;22:817-90.
46. Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ, van Kooyk Y, et al. A novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000;100:575-85.
47. Geijtenbeek TBH, van Vliet SJ, Engering A, t Hart BA, van Kooyk Y. Self-and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 2004;22:33-54.
48. Woltman AM, Schlagwein N, van der Kooij SW, van Kooten C. The novel cyclophilin-binding drug sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells. J Immunol 2004;172:6482-9.
49. Gordon EM, Gallop MA, Patel DV. Strategy and tactics in combinatorial organic synthesis. Applications to drug discovery. Acc Chem Res 1996;29:144-54.
50. Meredith JC, Sormana JL, Keselowsky BG, Garcia AJ, Tona A, Karim A, et al. Combinatorial characterization of cell interactions with polymer surfaces. J Biomed Mater Res A 2003;66 A: 483-90.
51. Zapata P, Su J, Garcia AJ, Meredith JC. Quantitative high-throughput screening of osteoblast attachment, spreading, and proliferation on demixed polymer blend micropatterns. Biomacromolecules 2007;8:1907-17.
52. Mei Y et al. Gradient substrate assembly for quantifying cellular response to biomaterials. J Biomed Mater Res A 2006;79 A: 974-88.
53. Brocchini S, James K, Tangpasuthadol V, Kohn J. Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res 1998;42:66-75.
54. Kohn J. New approaches to biomaterials design. Nat Mater 2004;3:745-7.